Influence of late treatment on how chronic myeloid leukemia responds to imatinib

INTRODUCTION: In Brazil, patients with chronic myeloid leukemia (CML) in the chronic phase were not given first-line imatinib treatment until 2008. Therefore, there was a long period of time between diagnosis and the initiation of imatinib therapy for many patients. This study aims to compare the ma...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Ana Carolina Costa Scerni, Leonardo Azevedo Alvares, Ana Cristina Beltrão, Iê Regina Bentes, Tereza Cristina Azevedo, Alessandra Quinto Bentes, José Alexandre Rodrigues Lemos
Format:	Artigo
Sprog:	Inglês
Udgivet:	Elsevier España 2009-01-01
Serier:	Clinics
Fag:	CML BCR-ABL Imatinib major molecular remission late treatment
Online adgang:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322009000800004
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!